Active Ingredient: BUDESONIDE
Proprietary Name: UCERIS
Dosage Form; Route of Administration: AEROSOL, FOAM; RECTAL
Strength: 2MG/ACTUATION
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N205613
Product Number: 001
Approval Date: Oct 7, 2014
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information